(Q72729410)
Statements
Adjuvant CMFVP versus tamoxifen versus concurrent CMFVP and tamoxifen for postmenopausal, node-positive, and estrogen receptor-positive breast cancer patients: a Southwest Oncology Group study (English)
S E Rivkin
S Green
B Metch
A B Cruz
M D Abeloff
W R Jewell
J J Costanzi
W B Farrar
J P Minton